JP6320447B2 - 前癌状態の胃癌検出キット及び前癌状態の胃癌細胞の検出方法 - Google Patents

前癌状態の胃癌検出キット及び前癌状態の胃癌細胞の検出方法 Download PDF

Info

Publication number
JP6320447B2
JP6320447B2 JP2016088283A JP2016088283A JP6320447B2 JP 6320447 B2 JP6320447 B2 JP 6320447B2 JP 2016088283 A JP2016088283 A JP 2016088283A JP 2016088283 A JP2016088283 A JP 2016088283A JP 6320447 B2 JP6320447 B2 JP 6320447B2
Authority
JP
Japan
Prior art keywords
gastric cancer
gastric
tissue sample
detecting
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016088283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017195803A (ja
JP2017195803A5 (https=
Inventor
隆 福山
隆 福山
憲忠 小林
憲忠 小林
博史 野々口
博史 野々口
真里子 荻
真里子 荻
等 山▲崎▼
等 山▲崎▼
禎人 高橋
禎人 高橋
八嗣 西
八嗣 西
信江 二渡
信江 二渡
玲 江間
玲 江間
和三郎 小泉
和三郎 小泉
嘉伸 市来
嘉伸 市来
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitasato Institute
Original Assignee
Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Institute filed Critical Kitasato Institute
Priority to JP2016088283A priority Critical patent/JP6320447B2/ja
Priority to PCT/JP2017/016543 priority patent/WO2017188315A1/ja
Publication of JP2017195803A publication Critical patent/JP2017195803A/ja
Publication of JP2017195803A5 publication Critical patent/JP2017195803A5/ja
Application granted granted Critical
Publication of JP6320447B2 publication Critical patent/JP6320447B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2016088283A 2016-04-26 2016-04-26 前癌状態の胃癌検出キット及び前癌状態の胃癌細胞の検出方法 Active JP6320447B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2016088283A JP6320447B2 (ja) 2016-04-26 2016-04-26 前癌状態の胃癌検出キット及び前癌状態の胃癌細胞の検出方法
PCT/JP2017/016543 WO2017188315A1 (ja) 2016-04-26 2017-04-26 早期胃癌検出キット及びその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016088283A JP6320447B2 (ja) 2016-04-26 2016-04-26 前癌状態の胃癌検出キット及び前癌状態の胃癌細胞の検出方法

Publications (3)

Publication Number Publication Date
JP2017195803A JP2017195803A (ja) 2017-11-02
JP2017195803A5 JP2017195803A5 (https=) 2018-01-11
JP6320447B2 true JP6320447B2 (ja) 2018-05-09

Family

ID=60159652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016088283A Active JP6320447B2 (ja) 2016-04-26 2016-04-26 前癌状態の胃癌検出キット及び前癌状態の胃癌細胞の検出方法

Country Status (2)

Country Link
JP (1) JP6320447B2 (https=)
WO (1) WO2017188315A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112534053A (zh) * 2018-06-21 2021-03-19 公立大学法人名古屋市立大学 胃癌生物标志物及其用途
JP7150312B2 (ja) * 2018-07-31 2022-10-11 学校法人北里研究所 胃癌細胞におけるｋｋ－ｌｃ－１の発現を予測する方法及びキット
JP6797423B2 (ja) * 2018-12-20 2020-12-09 学校法人北里研究所 胃組織試料が前癌状態であるか否かを判定する方法及びキット
CN109628457B (zh) * 2019-02-03 2021-12-10 淮海工学院 单链dna核酸适配体及其筛选方法与用途
CN112661812B (zh) * 2021-03-17 2021-06-15 南京鼓楼医院 一种kk-lc-1抗原靶向结合肽及其衍生物、探针与应用
KR20250057696A (ko) * 2022-09-02 2025-04-29 각코우호우징 기타사토켄큐쇼 헬리코박터 파일로리 제균 후의 환자에 있어서 위암의 발증 리스크를 평가하는 방법, 폴리뉴클레오티드 및 키트
CN117700493B (zh) * 2023-12-20 2026-04-17 南京鼓楼医院 一种kk-lc-1靶向结合蛋白及其衍生物、试剂盒和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6707248B2 (ja) * 2013-12-05 2020-06-10 学校法人北里研究所 胃癌細胞の検出方法、及び胃癌細胞検出キット
JP6028253B2 (ja) * 2015-01-28 2016-11-16 学校法人北里研究所 癌細胞の検出方法及び癌細胞検出キット

Also Published As

Publication number Publication date
JP2017195803A (ja) 2017-11-02
WO2017188315A1 (ja) 2017-11-02

Similar Documents

Publication Publication Date Title
JP6320447B2 (ja) 前癌状態の胃癌検出キット及び前癌状態の胃癌細胞の検出方法
Paulin et al. Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease
Hummelink et al. PD-1T TILs as a predictive biomarker for clinical benefit to PD-1 blockade in patients with advanced NSCLC
Zakhary et al. Impact of PIVKA-II in diagnosis of hepatocellular carcinoma
US20140178901A1 (en) Molecular Analysis of Tumor Samples
Ma et al. The prognostic values of CA125, CA19. 9, NSE, AND SCC for stage I NSCLC are limited
Ellingsen et al. Clinical activity of combined telomerase vaccination and pembrolizumab in advanced melanoma: results from a phase I trial
ES2856979T3 (es) Procedimientos de identificación de un individuo en función de si se va a tratar con quimioterapia en base a moléculas marcadoras y usos relacionados
US20170322216A1 (en) Pancreatic cancer diagnostic
CN112334487A (zh) 用于诊断和治疗癌症的组合物和方法
US20180292410A1 (en) Methods of detecting a relapse of a lung adenocarcinoma based on marker human epididymis protein 4 (he4) and related uses
JP7150312B2 (ja) 胃癌細胞におけるｋｋ－ｌｃ－１の発現を予測する方法及びキット
JP6361943B2 (ja) 補体因子ｂタンパク質に特異的に結合する抗体及び糖鎖抗原１９−９タンパク質に特異的に結合する抗体を含む膵臓癌診断用キット
JP6707248B2 (ja) 胃癌細胞の検出方法、及び胃癌細胞検出キット
Lee et al. A high-sensitivity cfDNA capture enables to detect the BRAF V600E mutation in papillary thyroid carcinoma
RU2010149266A (ru) Улучшенные способы иммуноанализа
Servais et al. An in vivo platform for tumor biomarker assessment
JP5145549B2 (ja) 腫瘍マーカー
Potempa-Jeziorowska Salivary biomarkers for monitoring the course of cancer development–real perspectives
CN115372618A (zh) 一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用
YEGANEH et al. The frequency of CA15-3, CA125, CA19-9 in Patients with Hepatitis B and C
Voronova et al. Evaluation and diagnostic potential of plasma biomarkers in bladder cancer
Oni et al. Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models
US20230358750A1 (en) Prognostic value of biomarkers in patients with non-small cell lung cancer having stable disease
Hanif et al. Significance of prostate specific antigen in prostate cancer patients and in non cancerous prostatic disease patients

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171120

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20171120

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20171206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180307

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180320

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180403

R150 Certificate of patent or registration of utility model

Ref document number: 6320447

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250